Skip to main content
MEDS
NASDAQ Life Sciences

DataMEDS Acquires Helomics AI Cancer Diagnostics Lab for $1.5M

Tom Rudovsky · Reported by ACCESS Newswire
More coverage: Consumer
Sentiment info
Positive
Importance info
7
Price
$1.62
Mkt Cap
$5.142M
52W Low
$0.823
52W High
$75
52W Position info
97% above low
Off High info
98% below high
Rel. Volume info
47× avg
Market data snapshot near publication time

MEDS sits 97% above its 52-week low of $0.823 on elevated volume (47× avg).

Summary

DataMEDS completed the acquisition of Helomics, an AI cancer diagnostics lab and precision oncology CRO, from Axe Compute for $1.5M in stock and a note, plus $1.5M cash. The deal brings a CLIA/CAP-certified lab, equipment, and the Predictive Oncology CRO business with no third-party debt. This expands DataMEDS into oncology, complementing its existing GLP-1 and Long COVID services. The transaction follows a period of financial strain for DataMEDS, including a $26.1M Q2 loss and going concern doubt, making this asset acquisition a notable strategic move. Axe Compute retains shareholder exposure to Helomics' future.

At the time of this announcement, MEDS was trading at $1.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.1M. The 52-week trading range was $0.82 to $75.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: ACCESS Newswire.


Price Chart

Share this article

Copied!

MEDS - Latest Insights

MEDS
Nov 16, 2026, 8:42 AM EST
Filing Type: PRE 14C
Importance Score:
8
Price at Filing: $0.7001
Real-time Price: $0.6221 info
Change: -$0.078 (-11%) info
Market Cap: $2.795M info
MEDS
Nov 16, 2026, 6:01 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.710
Real-time Price: $0.6221 info
Change: -$0.0879 (-12%) info
Market Cap: $2.795M info
MEDS
Nov 13, 2026, 5:12 PM EST
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.7251
Real-time Price: $0.6221 info
Change: -$0.103 (-14%) info
Market Cap: $2.795M info
MEDS
Nov 13, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.7499
Real-time Price: $0.6221 info
Change: -$0.1278 (-17%) info
Market Cap: $2.795M info
MEDS
Nov 13, 2026, 10:20 AM EST
Source: ACCESS Newswire
Importance Score:
8
Price at Filing: $0.8795
Real-time Price: $0.6221 info
Change: -$0.2574 (-29%) info
Market Cap: $2.795M info